The effect of Gami Guibitang (GGBT), a medicinal herbal formulation, on moderate depression

European Journal of Integrative Medicine

Volumn 4, Issue 4, 2012, Pages

  Han, Chang ho ^a   Chung, Myung il ^b   Bose, Shambhunath ^c   Lim, Chiyeon ^c   Kim, Hojun ^a   Koo, Byung Soo ^a   Pak, Sok Cheon ^d  

^a Dongguk University   (South Korea)

^b GunSei Biotec Inc   (South Korea)

^c Dongguk University College of Medicine   (South Korea)

^d CHARLES STURT UNIVERSITY   (Australia)

Author keywords

Adaptogens; Bodily Pain; Cortisol; Depression; Gami Guibitang

Indexed keywords

GAMI GUIBITANG; HYDROCORTISONE; PLACEBO; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DSM-IV; DYSTHYMIA; FEMALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SALIVA ANALYSIS; TREATMENT DURATION;

EID: 84872381086     PISSN: 18763820     EISSN: 18763839     Source Type: Journal    
DOI: 10.1016/j.eujim.2012.08.007     Document Type: Article

References (63)

1. WHO Mental and neurological disorders 'Depression' 2006.
2. Fava M., Kendler K.S. Major depressive disorder. Neuron 2000, 28:335-341.
3. Belmaker R.H., Agam G. Major depressive disorder. New England Journal of Medicine 2008, 358:55-68.
4. Holsboer F., Barden N. Antidepressants and hypothalamic-pituitary-adrenocortical regulation. Endocrine Reviews 1996, 17:187-205.
5. Nemeroff C.B., Vale W.W. The neurobiology of depression: inroads to treatment and new drug discovery. Journal of Clinical Psychiatry 2005, 66(Suppl. 7):5-13.
6. Nutt D.J. Relationship of neurotransmitters to the symptoms of major depressive disorder. Journal of Clinical Psychiatry 2008, 69(Suppl. E1):4-7.
7. Plotsky P.M., Owens M.J., Nemeroff C.B. Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. The Psychiatric clinics of North America 1998, 21:293-307.
8. Holsboer-Trachsler E., Brand S., Hatzinger M., Hemmeter U. Effects of Hypericum extract on sleep-EEG and DEX/CRH-test in patients with depression. Biological Psychiatry 2001, 49:9S.
9. Pariante C.M. Depression, stress and the adrenal axis. Journal of Neuroendocrinology 2003, 15:811-812.
10. Claes S.J. CRH, stress, and major depression: a psychobiological interplay. Vitamins and Hormones 2004, 69:117-150.
11. Ising M., Horstmann S., Kloiber S., Lucae S., Binder E.B., Kern N., et al. Combined dexamethasone/corticotropin releasing hormone test predicts treatment response in major depression - a potential biomarker?. Biological Psychiatry 2007, 62:47-54.
12. Vreeburg S.A., Hoogendijk W.J., van Pelt J., Derijk R.H., Verhagen J.C., van Dyck R., et al. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Archives of General Psychiatry 2009, 66:617-626.
13. Antonijevic I.A. Depressive disorders - is it time to endorse different pathophysiologies?. Psychoneuroendocrinology 2006, 31:1-15.
14. Shah P.J., Ebmeier K.P., Glabus M.F., Goodwin G.M. Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study. British Journal of Psychiatry 1998, 172:527-532.
15. Oldehinkel A.J., van den Berg M.D., Flentge F., Bouhuys A.L., ter Horst G.J., Ormel J. Urinary free cortisol excretion in elderly persons with minor and major depression. Psychiatry Research 2001, 104:39-47.
16. Watson S., Gallagher P., Del-Estal D., Hearn A., Ferrier I.N., Young A.H. Hypothalamic-pituitary-adrenal axis function in patients with chronic depression. Psychological Medicine 2002, 32:1021-1028.
17. Ehnvall A., Sjogren M., Zachrisson O.C., Agren H. HPA axis activation determined by the CRH challenge test in patients with few versus multiple episodes of treatment-refractory depression. European Archives of Psychiatry and Clinical Neuroscience 2004, 254:349-355.
18. Lindqvist D., Isaksson A., Träskman-Bendz L., Brundin L. Salivary cortisol and suicidal behavior - a follow up study. Psychoneuroendocrinology 2008, 33:1061-1068.
19. Fries E., Hesse J., Hellhammer J., Hellhammer D.H. A new view on hypocortisolism. Psychoneuroendocrinology 2005, 30:1010-1016.
20. Sarris J., Panossian A., Schweitzer I., Stough C., Scholey A. Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence. European Neuropsychopharmacology 2011, 21:841-860.
21. Dwyer A.V., Whitten D.L., Hawrelak J.A. Herbal medicines, other than St. John's wort, in the treatment of depression: a systematic review. Alternative Medicine Review 2010, 16(1):40-49.
22. Rose J. A natural approach to depression. Clinical Nutrition Insights 1998, 6(4):1-4.
23. Brekhman I.I., Dardymov I.V. New substances of plant origin which increase nonspecific resistance. Annual Review of Pharmacology 1969, 9:419-430.
24. Panossian A., Wikman G., Wagner H. Plant adaptogens. III. Earlier and more recent aspects and concepts on their mode of action. Phytomedicine 1999, 6:287-300.
25. Panossian A., Wikman G. Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine. Journal of Ethnopharmacology 2008, 118:183-212.
26. Olsson E.M., von Scheele B., Panossian A.G. A randomized, double-blind, placebo-controlled, parallel-group study of the standardized extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Medica 2009, 75:105-112.
27. Lee J., Lyu H.Y. A clinical study on the anti-stress effect by Lyu's Soyosan and Lyu's Kwipithang. Journal of Oriental Neuropsychiatry 1994, 5:41-60.
28. Kim H.J., Choi J.H., Lim S.W. The defensive effect of Keubi-tang on the gastric mucous membrane of mouse injured by stress and ethanol. Journal of Korean Oriental Medicine 2003, 24:155-168.
29. Park S.D., Park H.J., Chu W.S. Study on antioxidant activities of Guibitang and its component groups. Korean Journal of Herbology 2001, 16:11-27.
30. Lee J.A., Kim J.W., Whang W.W., Kwak S.Y., Kim M.J., Park E.H. The effects of Quibitang on an animal model of depression induced by chronic mild stress. Journal of Oriental Neuropsychiatry 2001, 12:123-135.
31. Lü J.M., Yao Q., Chen C. Ginseng compounds: an update on their molecular mechanisms and medical applications. Current Vascular Pharmacology 2009, 7:293-302.
32. Attele A.S., Wu J.A., Yuan C.S. Ginseng pharmacology: multiple constituents and multiple actions. Biochemical Pharmacology 1999, 58:1685-1693.
33. Dang H., Chen Y., Liu X., Wang Q., Wang L., Jia W., et al. Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009, 33(8):1417-1424.
34. Lin Z., Gu J., Xiu J., Mi T., Dong J., Tiwari J.K. Traditional Chinese medicine for senile dementia. Evidence-Based Complementary and Alternative Medicine 2012, 692621.
35. Li F.L., Wang Y.F., Li X., Li F., Xu R., Chen J., et al. Characteristics and clinical managements of chronic skin ulcers based on traditional Chinese medicine. Evidence-Based Complementary and Alternative Medicine 2012, 930192.
36. Wu T.H., Chen I.C., Chen L.C. Antacid effects of Chinese herbal prescriptions assessed by a modified artificial stomach model. World Journal of Gastroenterology 2010, 16:4455-4459.
37. Modern medicine traditional Chinese medicine: diabetes mellitus. Part 3. Journal of Chinese Medicine 1999, 60:27-36.
38. Li W.L., Zheng H.C., Bukuru J., De Kimpe N. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. Journal of Ethnopharmacology 2004, 92:1-21.
39. Cho H.Y. Oriental medicine: a modern interpretation 1996, Yuin University Press, Compton, CA.
40. Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry 1960, 23:56-62.
41. Bagby R.M., Ryder A.G., Schuller D.R., Marshall M.B. The Hamilton Depression Rating Scale: has the gold standard become a lead weight?. American Journal of Psychiatry 2004, 161:2163-2177.
42. Yi J.S., Bae S.O., Ahn Y.M., Park D.B., Noh K.S., Shin H.K., et al. Validity and reliability of the Korean version of the Hamilton Depression Rating Scale (K-HDRS). Journal of Korean Neuropsychiatric Association 2005, 44:456-465.
43. Laudat M.H., Cerdas S., Fournier C., Guiban D., Guilhaume B., Luton J.P. Salivary cortisol measurement: a practical approach to assess pituitary-adrenal function. Journal of Clinical Endocrinology and Metabolism 1998, 66:343-348.
44. Raff H., Raff J.L., Findling J.W. Late-night salivary cortisol as a screening test for Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 1998, 83:2681-2686.
45. Wüst S., Wolf J., Hellhammer D.H., Federenko I., Schommer N., Kirschbaum C. The cortisol awakening response - normal values and confounds. Noise Health 2000, 2:79-88.
46. Aardal E., Holm A.C. Cortisol in saliva - reference ranges and relation to cortisol in serum. European Journal of Clinical Chemistry and Clinical Biochemistry 1995, 33:927-932.
47. Murck H. Atypical depression spectrum disorder-neurobiology treatment. Acta Neuropsychiatrica 2003, 15:227-241.
48. Gold P.W., Chrousos G.P. Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states. Molecular Psychiatry 2002, 7:254-275.
49. Levitan R.D., Vaccarino F.J., Brown G.M., Kennedy S.H. Low-dose dexamethasone challenge in women with atypical major depression: pilot study. Journal of Psychiatry and Neuroscience 2002, 27:47-51.
50. Shelton R.C., Keller M.B., Gelenberg A., Dunner D.L., Hirschfeld R., Thase M.E., et al. Effectiveness of St. John's wort in major depression; a randomized controlled trial. JAMA: The Journal of the American Medical Association 2001, 285:1978-1986.
51. Effect of Hypericum perforatum (St. John's wort) in major depressive disorder; a randomized controlled trial. JAMA: The Journal of the American Medical Association 2002, 287:1807-1814. Hypericum Depression Trial Study Group.
52. Mannel M., Kuhn U., Schmidt U., Ploch M., Murck H. St. John's wort extract LI160 for the treatment of depression with atypical features - a double-blind, randomized, and placebo-controlled trial. Journal of Psychiatric Research 2010, 44:760-767.
53. Geiss A., Varadi E., Steinbach K., Bauer H.W., Anton F. Psychoneuroimmunological correlates of persisting sciatic pain in patients who underwent discectomy. Neuroscience Letters 1997, 237:65-68.
54. Adler G.K., Manfredsdottir V.F., Creskoff K.W. Neuroendocrine abnormalities in fibromyalgia. Current Pain and Headache Reports 2002, 6:289-298.
55. Geiss A., Rohleder N., Kirschbaum C., Steinbach K., Bauer H.W., Anton F. Predicting the failure of disc surgery by a hypofunctional HPA axis: evidence from a prospective study on patients undergoing disc surgery. Pain 2005, 114:104-117.
56. Johansson A.C., Gunnarsson L.G., Linton S.J., Bergkvist L., Stridsberg M., Nilsson O., et al. Pain, disability and coping reflected in the diurnal cortisol variability in patients scheduled for lumbar disc surgery. European Journal of Pain 2008, 12:633-640.
57. Franklin M., Hafizi S., Reed A., Hockney R., Murck H. Effect of sub-chronic treatment with Jarsin (extract of St John's wort, Hypericum perforatum) at two dose levels on evening salivary melatonin and cortisol concentrations in healthy male volunteers. Pharmacopsychiatry 2006, 39:13-15.
58. Munck A., Guyre P.M., Holbrook N.J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocrine Reviews 1984, 5:25-44.
59. Romundstad L., Breivik H., Stubhaug A. Glucocorticoids reduce acute postoperative pain. Tidsskrift for Den Norske Laegeforening 2005, 125:2507-2508.
60. Pinto-Ribeiro F., Almeida A., Pêgo J.M., Cerqueira J., Sousa N. Chronic unpredictable stress inhibits nociception in male rats. Neuroscience Letters 2004, 359:73-76.
61. Capasso A., Giannuario A., Liozzo A., Pieretti S., Sorrentino L. Central interaction of dexamethasone and mifepristone (RU486) on morphine antinociception in mice. Life Sciences 1992, 51:L139-L143.
62. Pieretti S., Capasso A., Giannuario A., Liozzo A., Sorrentino L. The interaction of peripherally and centrally administered dexamethasone and RU486 on morphine analgesia in mice. General Pharmacology 1991, 22:929-933.
63. O'Connor T.M., O'Halloran D.J., Shanahan F. The stress response and the hypothalamic-pituitary-adrenal axis: from molecule to melancholia. Quarterly Journal of Medicine 2000, 93:323-333.